# Cosmos Health (COSM) — News COSM · NASDAQ · Stock Canonical page: https://www.lighthorse.io/tickers/cosm/news ## Recent headlines - [WallStreetBets stocks rose in after-hours trading, with IonQ up 1.3%, Lot up 8.3% and Kosmos Health gaining 2.2%.](https://www.ainvest.com/news/wallstreetbets-stocks-rose-hours-trading-ionq-1-3-lot-8-3-kosmos-health-gaining-2-2-2610-3) — AInvest Wire, Oct 12, 2026 After-hours trading on October 12, 2026, saw notable gains among several stocks previously associated with the WallStreetBets community. IonQ, a quantum computing company, rose 1.3%, while Lot, a digital collectibles platform, surged 8.3%. Kosmos Health, a provider of digital health solutions,… - [Cosmos Health Q3 revenue USD 17.4 million](https://www.ainvest.com/news/cosmos-health-q3-revenue-usd-17-4-million-2610) — AInvest Wire, Oct 7, 2026 Cosmos Health Inc. (NASDAQ: COSM) reported third-quarter revenue of $17.4 million for the period ending September 30, 2026, reflecting continued growth across its core business segments. This performance aligns with the company’s full-year 2025 results, which saw a 20% year-over-year revenue… - [Cosmos Health Inc: Contract manufacturing pipeline of Cana Laboratories S.A. has surpassed $20 mln in implied rev over life of underlying agreement](https://www.ainvest.com/news/cosmos-health-contract-manufacturing-pipeline-cana-laboratories-surpassed-20-mln-implied-rev-life-underlying-agreement-2609) — AInvest Wire, Sep 28, 2026 Cosmos Health Inc. (NASDAQ: COSM) has reported that the contract manufacturing pipeline of its subsidiary, Cana Laboratories S.A., has surpassed $20 million in implied revenue over the life of the underlying agreements. This development underscores the growing demand for Cana’s manufacturing… - [Cosmos Health: Prime Ledger to structure tokenized financing backed by IP in CCX0722, an ingestible device in development for weight management](https://www.ainvest.com/news/cosmos-health-prime-ledger-structure-tokenized-financing-backed-ip-ccx0722-ingestible-device-development-weight-management-2609) — AInvest Wire, Sep 14, 2026 Cosmos Health has announced plans to pursue tokenized financing for its CCX0722 ingestible weight management device, with Prime Ledger serving as the structuring partner. The initiative aims to leverage Cosmos Health’s intellectual property (IP) related to the development of CCX0722, an ingestible… - [Cosmos Health: Secures additional 2.5 mln units under new five-year contract manufacturing agreement with Viofar](https://www.ainvest.com/news/cosmos-health-secures-additional-2-5-mln-units-year-contract-manufacturing-agreement-viofar-2609) — AInvest Wire, Sep 11, 2026 Cosmos Health Inc. has entered into a five-year contract manufacturing agreement with Viofar, under which it will supply an additional 2.5 million units of pharmaceutical products. The agreement marks a significant expansion of the company’s manufacturing commitments and reflects ongoing demand for… --- Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express. This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness. Data provided by [AInvest](https://www.ainvest.com).